bf/NASDAQ:TXG_icon.jpeg

COM:10XGENOMICS

10x Genomics, Inc.

  • Stock

Last Close

13.29

22/11 21:00

Market Cap

1.88B

Beta: -

Volume Today

4.50M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
6.70M
-
11.92M
77.80%
22.61M
89.72%
44.96M
98.82%
70.80M
57.46%
77.67M
9.70%
average payables
7.12M
-
10.91M
53.28%
8.87M
18.71%
11.03M
24.37%
19.48M
76.56%
18.67M
4.14%
average receivables
21.45M
-
31.47M
46.68%
42.29M
34.39%
68.23M
61.34%
94.73M
38.84%
109.52M
15.61%
book value per share
-1.45
-
-2.65
82.80%
10.75
504.92%
7.31
32.01%
7.41
1.40%
7.08
4.49%
6.32
10.63%
capex per share
-0.05
-
-0.08
66.99%
-1.09
1,251.70%
-0.38
65.31%
-0.92
141.80%
-1.16
25.99%
-0.42
63.45%
capex to depreciation
-0.87
-
-1.72
96.92%
-6.05
252.29%
-2.02
66.65%
-3.58
77.58%
-3.99
11.28%
-1.14
71.54%
capex to operating cash flow
0.35
-
0.09
74.99%
-1.24
1,506.63%
0.18
114.27%
4.74
2,589.30%
3.92
17.32%
3.26
16.82%
capex to revenue
-0.05
-
-0.05
13.22%
-0.17
279.30%
-0.13
26.13%
-0.21
60.72%
-0.25
23.47%
-0.08
68.61%
cash per share
0.62
-
0.79
27.14%
10.85
1,282.03%
6.56
39.54%
5.32
18.85%
3.78
29.06%
3.32
12.15%
days of inventory on hand
167.22
-
109.14
34.73%
91.32
16.33%
187.03
104.80%
295.41
57.95%
247.49
16.22%
128.47
48.09%
days payables outstanding
188.13
-
111.97
40.49%
77.91
30.41%
29.40
62.27%
85.48
190.77%
65.49
23.39%
27.43
58.11%
days sales outstanding
68.50
-
73.76
7.67%
49.54
32.84%
62.54
26.26%
63.44
1.44%
73.66
16.10%
67.74
8.03%
debt to assets
0.14
-
0.24
70.94%
0.05
79.45%
0.07
38.16%
0.08
18.74%
0.09
14.95%
0.10
6.83%
debt to equity
-0.09
-
-0.13
43.74%
0.07
152.44%
0.09
20.45%
0.10
17.67%
0.12
17.80%
0.13
8.95%
dividend yield
earnings yield
-0.00
-
-0.03
460.50%
-0.01
59.24%
-0.04
261.41%
-0.00
90.65%
-0.04
1,029.54%
-0.04
2.75%
enterprise value
4.05B
-
4.34B
7.07%
2.59B
40.37%
13.72B
430.59%
15.93B
16.10%
4.02B
74.74%
6.29B
56.36%
enterprise value over ebitda
-297.29
-
-330.05
11.02%
-97.77
70.38%
-166.42
70.22%
-297.74
78.91%
-24.92
91.63%
-39.76
59.57%
ev to operating cash flow
-378.59
-
-56.76
85.01%
74.69
231.58%
-62.98
184.32%
-745.42
1,083.66%
-119.75
83.93%
-414.07
245.77%
ev to sales
56.98
-
29.64
47.98%
10.52
64.52%
45.92
336.57%
32.48
29.26%
7.79
76.01%
10.17
30.50%
free cash flow per share
-0.19
-
-1.00
437.58%
-0.21
79.23%
-2.53
1,116.80%
-1.11
56.13%
-1.45
30.59%
-0.55
61.94%
free cash flow yield
-0.00
-
-0.02
437.58%
-0.00
85.63%
-0.02
555.23%
-0.01
58.30%
-0.04
433.83%
-0.01
75.22%
graham net net
-1.65
-
-3.05
84.85%
6.93
327.34%
5.21
24.88%
4.35
16.44%
2.86
34.25%
2.45
14.20%
graham number
2.81
-
9.00
220.09%
13.90
54.45%
29.70
113.62%
9.38
68.42%
15.24
62.46%
17.60
15.53%
income quality
0.57
-
0.68
19.12%
-1.11
263.12%
0.40
136.23%
0.37
8.57%
0.20
44.85%
0.06
70.57%
intangibles to total assets
0
-
0
0
0.02
Infinity%
0.03
22.04%
0.03
9.39%
0.02
17.70%
interest coverage
-22.66
-
-45.98
102.93%
-9.44
79.47%
-50.73
437.27%
-61.10
20.45%
-352.82
477.45%
-6.12K
1,633.79%
interest debt per share
0.15
-
0.39
163.82%
0.84
116.76%
0.64
23.81%
0.75
17.44%
0.84
11.90%
0.81
3.07%
inventory turnover
2.18
-
3.34
53.22%
4.00
19.51%
1.95
51.17%
1.24
36.69%
1.47
19.36%
2.84
92.65%
invested capital
-0.09
-
-0.13
43.74%
0.07
152.44%
0.09
20.45%
0.10
17.67%
0.12
17.80%
0.13
8.95%
market cap
4.09B
-
4.37B
6.96%
2.98B
31.83%
14.32B
380.52%
16.44B
14.76%
4.15B
74.76%
6.56B
58.03%
net current asset value
-120.01M
-
-238.06M
98.37%
295M
223.92%
584.10M
98.00%
546.33M
6.47%
411.80M
24.63%
371.92M
9.68%
net debt to ebitda
2.74
-
2.69
1.58%
14.91
453.49%
7.28
51.15%
9.45
29.68%
0.77
91.83%
1.67
116.21%
net income per share
-0.24
-
-1.36
460.50%
-0.80
41.09%
-5.37
571.16%
-0.53
90.17%
-1.46
176.32%
-2.18
49.34%
operating cash flow per share
-0.14
-
-0.92
567.67%
0.89
196.09%
-2.15
343.19%
-0.19
91.01%
-0.30
52.39%
-0.13
56.06%
payables turnover
1.94
-
3.26
68.03%
4.68
43.71%
12.42
165.03%
4.27
65.61%
5.57
30.53%
13.31
138.73%
receivables turnover
5.33
-
4.95
7.12%
7.37
48.90%
5.84
20.80%
5.75
1.42%
4.96
13.87%
5.39
8.73%
research and ddevelopement to revenue
0.45
-
0.32
28.19%
0.34
4.01%
0.41
22.16%
0.43
4.57%
0.51
19.16%
0.44
15.07%
return on tangible assets
-0.25
-
-0.90
264.66%
-0.05
94.30%
-0.60
1,060.21%
-0.06
90.16%
-0.17
181.50%
-0.27
63.05%
revenue per share
0.92
-
1.77
92.43%
6.29
256.36%
2.95
53.03%
4.44
50.45%
4.54
2.04%
5.28
16.43%
roe
0.17
-
0.51
206.62%
-0.07
114.55%
-0.73
887.12%
-0.07
90.30%
-0.21
189.29%
-0.34
67.09%
roic
0.18
-
0.58
222.81%
-0.07
111.17%
-0.10
53.89%
-0.06
41.66%
-0.17
195.72%
-0.22
30.18%
sales general and administrative to revenue
shareholders equity per share
-1.45
-
-2.65
82.80%
10.75
504.92%
7.31
32.01%
7.41
1.40%
7.08
4.49%
6.32
10.63%
stock based compensation to revenue
0.02
-
0.02
22.25%
0.05
198.48%
0.16
200.08%
0.20
20.24%
0.26
35.45%
0.27
1.82%
tangible asset value
-112.51M
-
-219.99M
95.53%
420.08M
290.96%
716.72M
70.61%
787.66M
9.90%
778.37M
1.18%
719.92M
7.51%
tangible book value per share
-1.45
-
-2.65
82.80%
10.75
504.92%
7.09
34.06%
7.14
0.74%
6.84
4.23%
6.14
10.12%
working capital
45.97M
-
73.87M
60.71%
417.79M
465.55%
656.24M
57.07%
637.23M
2.90%
504.08M
20.90%
468.86M
6.99%

All numbers in (except ratios and percentages)